These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 819140)

  • 21. Primary in vitro antibody formation by blood leucocytes of a subhuman primate.
    Nickerson DA; Gengozian N
    Cell Immunol; 1976 Dec; 27(2):171-6. PubMed ID: 827334
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfer factor therapy in patients with cancer.
    Vetto RM; Burger DR; Nolte JE; Vandenbark AA; Baker HW
    Cancer; 1976 Jan; 37(1):90-7. PubMed ID: 1247971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs.
    Meyer KF; Smith G; Foster L; Brookman M; Sung M
    J Infect Dis; 1974 May; 129():Suppl:S85-12. PubMed ID: 4207627
    [No Abstract]   [Full Text] [Related]  

  • 25. Serial transfer of delayed hypersensitivity with dialyzable transfer factor.
    Kirkpatrick CH; Smith TK
    Cell Immunol; 1976 Dec; 27(2):323-7. PubMed ID: 795550
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of bovine transfer factor (TFd) in mouse coccidiosis (Eimeria ferrisi).
    Klesius PH; Qualls DF; Elston AL; Fudenberg HH
    Clin Immunol Immunopathol; 1978 Jun; 10(2):214-21. PubMed ID: 668216
    [No Abstract]   [Full Text] [Related]  

  • 27. Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor.
    Gerbase-DeLima M; Carlquist I; Mendes NF
    Cell Immunol; 1979 Nov; 48(1):231-4. PubMed ID: 509535
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro and in vivo modulation of cellular immunity using human transfer factor].
    Gordienko SM; Avdiunicheva OE; Saiapina NV
    Gematol Transfuziol; 1987 Jan; 32(1):39-43. PubMed ID: 3817424
    [No Abstract]   [Full Text] [Related]  

  • 29. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation.
    Rosso di San Secondo VE; Lugaro G; Sirchia G
    J Exp Pathol; 1987; 3(4):425-7. PubMed ID: 3454803
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
    Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
    Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Transfer-factor therapy in multiple sclerosis.
    Jersild C; Platz P; Thomsen M; Hansen GS; Svejgaard A; Dupont B; Fog T; Ciongoli AK; Grob P
    Lancet; 1973 Dec; 2(7842):1381-2. PubMed ID: 4128065
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfer of cellular immunity with transfer factor.
    Kirkpatrick CH
    J Allergy Clin Immunol; 1979 Feb; 63(2):71-3. PubMed ID: 759465
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood group antigens in primate animals and their relation to human blood groups.
    Moor-Jankowski J; Wiener AS
    Primates Med; 1969; 3(0):64-77. PubMed ID: 4135386
    [No Abstract]   [Full Text] [Related]  

  • 34. Transfer of cell-mediated immunity in leprosy by transfer of lymph node cells.
    Antia NH; Khanolkar SR
    Int J Lepr Other Mycobact Dis; 1974; 42(1):28-32. PubMed ID: 4472411
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.
    Schulking ML; Adler WH; Altemeier WA; Ayoub EM
    Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic pulmonary histoplasmosis: improved lymphocyte response with transfer factor.
    Smith CR; Griffin DE; Graybill JR
    Ann Intern Med; 1976 Jun; 84(6):708-9. PubMed ID: 937885
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival of serum proteins transfused between primate species determined by antiglobulin inhibition.
    Socha WW; Wiener AS; Kaczera Z; Gordon EB
    J Med Primatol; 1972; 1(5):304-8. PubMed ID: 4121213
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfer factor therapy in immuno-deficiencies.
    Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigenic factors characteristic of human immunoglobulin G, detected in the sera of non-human primates.
    Alepa FP
    Primates Med; 1968; 1(0):1-9. PubMed ID: 5006015
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfer factor].
    Chaves MA
    Arq Patol; 1973 Apr; 45(1):23-6. PubMed ID: 4797660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.